||5R21CA225623-02 Interpret this number
||Cedars-Sinai Medical Center
||Identification of Microbial Biomarkers for Hepatocellular Carcinoma in a Multi-Ethnic Population of Patients with Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) related hepatocellular carcinoma (HCC) is a growing public health
problem, and the burden is disproportionately carried by racial and ethnic minority populations. There is an
urgent need to gain a better understanding of the underlying biological mechanisms responsible for why some
people with NAFLD are more prone to developing HCC, and the causes for disparities in NAFLD related HCC.
Experimental data show that the composition and products of the gut microbiome, many of which have
established relationship with obesity and/or a high fat diet, are carcinogenic to the liver. Our preliminary data
suggest that there are ethnic differences in microbial composition in a cirrhotic population at high risk for HCC,
and that certain metabolites can differentiate cirrhotics with HCC from those without HCC. In the proposed
case-control study, we will examine the contributions of race/ethnicity, fecal microbiome, fecal metabolome,
and host factors (e.g. specific dietary factors and markers of body and liver fat composition) to NAFLD related
HCC. Importantly, we have constructed a multi-disciplinary and collaborative research team with the required
scientific expertise in microbiology, informatics, statistics, cancer epidemiology, and NAFLD biology; and the
right clinical partnerships to succeed with the targeted patient recruitment required to address the specific
aims. We will recruit 225 study participants with NAFLD and with HCC (N=75) and without HCC (N=150), over
1.25 months. Participants will be recruited from two neighboring clinical centers that care for a large proportion
of Hispanics and African Americans in Los Angeles, two groups that are at the highest risk for HCC and stand
to gain the most from the proposed research. Study participants will provide fecal, urine, and blood specimens;
epidemiological data; clinical data; and nutritional data. Over the last 6 months of the project, we will perform
laboratory testing and statistical modeling. We will use a combination of mixed effects logistic regression
models, and integrative analytic approaches, to understand the contribution of our laboratory, epidemiological,
and clinical data to NAFLD-HCC. The information gained from this study may open prospects for therapeutic
interventions that could delay or avert HCC in these vulnerable at-risk populations.
Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study.
, Dong T.S.
, Agopian V.
, Lagishetty V.
, Sundaram V.
, Noureddin M.
, Ayoub W.S.
, Durazo F.
, Benhammou J.
, Enayati P.
, et al.
Hepatology research : the official journal of the Japan Society of Hepatology, 2018 Dec; 48(13), p. 1108-1117.